Understand the source comparison
Peptides Help With Anti-Aging: Clinical Trial Evidence vs Marketing Claims
Palmitoyl Pentapeptide-4 (Matrixyl) TGF-β receptor agonist. Stimulates procollagen I synthesis 18% increase in collagen density (12 weeks, ultrasound-verified). Journal of Cosmetic Dermatology 2023 3–8 ppm in serums Gold standard for topical collagen stimulati
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Palmitoyl Pentapeptide-4 (Matrixyl)
- TGF-β receptor agonist. Stimulates procollagen I synthesis
- 18% increase in collagen density (12 weeks, ultrasound-verified). Journal of Cosmetic Dermatology 2023
- 3–8 ppm in serums
- Gold standard for topical collagen stimulation. Mechanism confirmed, effect reproducible
- GHK-Cu (Copper Peptide)
- Copper delivery to SOD/lysyl oxidase enzymes. Antioxidant + collagen cross-linking
- 47% increase in SOD activity, improved wound healing markers. Pickart et al. 2012
- 1–5 ppm in serums
- Strong evidence for repair pathways. Less data on long-term anti-aging vs acute wound healing
- Acetyl Hexapeptide-8 (Argireline)
- SNARE complex inhibitor. Reduces neurotransmitter release at neuromuscular junctions
- 30% reduction in wrinkle depth (topical, 30 days). International Journal of Cosmetic Science 2002
- 5–10 ppm in serums
- Works for expression lines. Effect magnitude weaker than botulinum toxin, requires continuous use
- Growth Hormone Secretagogues (Hexarelin, Ipamorelin)
- Ghrelin receptor agonist. Systemic GH/IGF-1 elevation
- 7.1% dermal thickness increase (6 months, subcutaneous injection). JCEM 2021
- Not applicable (injectable only)
- Systemic effects confirmed. Regulatory constraints limit cosmetic use, research context only
- Thymosin Beta-4 Fragment (TB-500)
- Actin-binding protein. Promotes cell migration and angiogenesis
- Improved wound closure rates in animal models. Limited human RCT data
- Not used in cosmetics
- Promising repair mechanism. Insufficient clinical data for definitive anti-aging claims